Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases

Clinical Infectious Diseases

Volumn 40, Issue 3, 2005, Pages 392-398

  Yoo, Jin Hong ^a,b   Choi, Jung Hyun ^a   Choi, Su Mi ^a   Lee, Dong Gun ^a   Shin, Wan Shik ^a   Min, Woo Sung ^a   Kim, Chun Choo ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Holy Family Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; GALACTOMANNAN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; ASPERGILLOSIS; BLOOD SAMPLING; CANCER CHEMOTHERAPY; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME IMMUNOASSAY; FEBRILE NEUTROPENIA; FEMALE; GALACTOMANNAN ENZYME IMMUNOSORBENT ASSAY; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; FEMALE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LUNG DISEASES, FUNGAL; MALE; MANNANS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 13444274289     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/427284     Document Type: Article

References (26)

1. Giamarellou H, Antoniadou A. Infectious complications of febrile leucopenia. Infect Dis Clin North Am 2001; 15:457-82.
2. Winfried VK. Current epidemiology of infections in neutropenic cancer patients. In: Kenneth VIR, Edward BR, eds. Textbook of febrile neutropenia. London: Martin Dunitz, 2001:57.
3. Van den Bergh MF, Verweij PE, Voss A. Epidemiology of nosocomial fungal infections: invasive aspergillosis and the environment. Diagn Microbiol Infect Dis 1999; 34:221-7.
4. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26:781-805.
5. Yeo SI, Wong B. Current status of non-culture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002; 15:465-84.
6. Verweij PE, Poulain D, Obayashi T, Patterson TF, Denning DW, Ponton J. Current trends in the detection of antigenaemia, metabolites, and cell wall markers for the diagnosis and therapeutic monitoring of fungal infections. Med Mycol 1998; 36(Suppl 1):146-55.
7. Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995; 33:497-500.
8. Boutboul F, Albert C, Leblanc T, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis 2002; 34:939-43.
9. Stevens DA. Diagnosis of fungal infections: current status. J Antimicrob Chemother 2002; 49(Suppl 1):11-9.
10. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14.
11. Compton J. Nucleic acid sequence-based amplification. Nature 1991; 350:91-2.
12. Blok MJ, Goossens VJ, Vanherle SJV, et al. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification. J Clin Microbiol 1998; 36:1341-6.
13. Damen M, Sillekens P, Cuypers HT, Frantzen I, Melsert R. Characterization of the quantitative HCV NASBA assay. J Virol Methods 1999; 82:45-54.
14. Ginocchio GC, Kemper M, Stellrecht KA, Witt DJ. Multicenter evaluation of the performance characteristics of the NucliSens HIV-1 QT assay used for quantitation of human immunodeficiency virus type 1 RNA. J Clin Microbiol 2003; 41:164-73.
15. Loeffler J, Hebart H, Cox P, Flues N, Schumacher U, Einsele H. Nucleic acid sequence-based amplification of Aspergillus RNA in blood samples. J Clin Microbiol 2001; 39:1626-9.
16. Sulahian A, Tabouret M, Ribaud P, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1996; 15:139-45.
17. Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37:3223-8.
18. Maertens J, van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186:1297-306.
19. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97:1604-10.
20. Pinel C, Fricker-Hidalgo H, Lebeau B, et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 2003; 41:2184-6.
21. Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-β-D-glucan test in: weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42:2733-41.
22. Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4:349-57.
23. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C. Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001; 91:311-8.
24. Jones BL, McLintock LA. Impact of diagnostic markers on early antifungal therapy. Curr Opin Infect Dis 2003; 16:521-6.
25. Becker MJ, de Marie S, Williemse D, Verbrugh HA, Bakker-Woudenberg IA. Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol 2000; 38:1434-8.
26. Marino IR, Panarello G, Singh N. Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients. Transpl Infect Dis 2002; 4:226-7.